Synergy and Mechanism of Leflunomide Plus Fluconazole Against Resistant Candida albicans: An in vitro Study

References

• Gow NAR, Yadav B. Microbe profile: Candida albicans: a shape-changing, opportunistic pathogenic fungus of humans. Microbiology. 2017;163:1145–1147. doi:10.1099/mic.0.000499
   PubMed Web of Science ®Google Scholar
• Robbins N, Caplan T, Cowen LE. Molecular evolution of antifungal drug resistance. Annu Rev Microbiol. 2017;71(1):753–775. doi:10.1146/annurev-micro-030117-020345
   PubMedGoogle Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133–163. doi:10.1128/CMR.00029-06
   PubMed Web of Science ®Google Scholar
• Naveen KV, Saravanakumar K, Sathiyaseelan A, et al. Human fungal infection, immune response, and clinical challenge-a perspective during COVID-19 pandemic. Appl Biochem Biotechnol. 2022;194(9):4244–4257. doi:10.1007/s12010-022-03979-5
   PubMedGoogle Scholar
• Chavda VP, Mishra T, Kamaraj S, et al. Post-COVID-19 fungal infection in the aged population. Vaccines. 2023:11. doi:10.3390/vaccines11030555
   Web of Science ®Google Scholar
• Hoenigl M, Seidel D, Sprute R, et al. COVID-19-associated fungal infections. Nat Microbiol. 2022;7(8):1127–1140. doi:10.1038/s41564-022-01172-2
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. World Health Organization; 2022.
   Google Scholar
• Liu S, Yue L, Gu W, et al. Synergistic effect of fluconazole and calcium channel blockers against resistant Candida albicans. PLoS One. 2016;11(3):e0150859. doi:10.1371/journal.pone.0150859
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhang C, Lu C, et al. Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers. FEMS Yeast Res. 2013;13(5):453–462. doi:10.1111/1567-1364.12048
   PubMed Web of Science ®Google Scholar
• Sun S, Li Y, Guo Q, et al. In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. Antimicrob Agents Chemother. 2008;52(2):409–417. doi:10.1128/AAC.01070-07
   PubMed Web of Science ®Google Scholar
• Wibawa T, Baly I, Daeli PR, et al. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth. Trop Biomed. 2015;32:176–182.
   PubMed Web of Science ®Google Scholar
• Zhang M, Qi C, Zha Y, et al. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial. Clin Rheumatol. 2019;38(3):859–867. doi:10.1007/s10067-018-4348-z
   PubMed Web of Science ®Google Scholar
• Zhang C, Chu M. Leflunomide: a promising drug with good antitumor potential. Biochem Biophys Res Commun. 2018;496(2):726–730. doi:10.1016/j.bbrc.2018.01.107
   PubMed Web of Science ®Google Scholar
• Li Y, Sun S, Guo Q, et al. In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. J Antimicrob Chemother. 2008;61(3):577–585. doi:10.1093/jac/dkm493
   PubMed Web of Science ®Google Scholar
• Li X, Yu C, Huang X, et al. Synergistic effects and mechanisms of budesonide in combination with fluconazole against resistant Candida albicans. PLoS One. 2016;11(12):e0168936. doi:10.1371/journal.pone.0168936
   PubMed Web of Science ®Google Scholar
• Rex JH, Alexander BD, Andes D, et al. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard—Third Edition. Vol. 28. CLSI; 2008.
   Google Scholar
• Savage KA, Parquet MC, Allan DS, et al. Iron restriction to clinical isolates of Candida albicans by the novel chelator DIBI inhibits growth and increases sensitivity to azoles in vitro and in vivo in a murine model of experimental vaginitis. Antimicrob Agents Chemother. 2018;62. doi:10.1128/AAC.02576-17
   PubMed Web of Science ®Google Scholar
• Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52(1):1. doi:10.1093/jac/dkg301
   PubMed Web of Science ®Google Scholar
• Chen X, Shi Y, Li Y, et al. Antifungal effects and potential mechanisms of lonidamine in combination with fluconazole against Candida albicans. Expert Rev Anti Infect Ther. 2021;19(1):109–115. doi:10.1080/14787210.2020.1811684
   PubMed Web of Science ®Google Scholar
• Chang W, Li Y, Zhang L, et al. Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production. PLoS One. 2012;7(7):e41624. doi:10.1371/journal.pone.0041624
   PubMed Web of Science ®Google Scholar
• Wang T, Flint S, Palmer J. Magnesium and calcium ions: roles in bacterial cell attachment and biofilm structure maturation. Biofouling. 2019;35(9):959–974. doi:10.1080/08927014.2019.1674811
   PubMed Web of Science ®Google Scholar
• Weissman L, Garty J, Hochman A. Rehydration of the Lichen Ramalina lacera results in production of reactive oxygen species and nitric oxide and a decrease in antioxidants. Appl Environ Microbiol. 2005;71(4):2121–2129. doi:10.1128/AEM.71.4.2121-2129.2005
   PubMed Web of Science ®Google Scholar
• Li Y, Jiao P, Li Y, et al. The synergistic antifungal effect and potential mechanism of D-penicillamine combined with fluconazole against Candida albicans. Front Microbiol. 2019;10:2853. doi:10.3389/fmicb.2019.02853
   PubMed Web of Science ®Google Scholar
• Zhang M, Yan H, Lu M, et al. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence. Int J Antimicrob Agents. 2020;55(1):105804. doi:10.1016/j.ijantimicag.2019.09.008
   PubMed Web of Science ®Google Scholar
• Li X, Sun S. Targeting the fungal calcium-calcineurin signaling network in overcoming drug resistance. Future Med Chem. 2016;8:1379–1381. doi:10.4155/fmc-2016-0094
   PubMed Web of Science ®Google Scholar
• Tian J, Lu Z, Wang Y, et al. Nerol triggers mitochondrial dysfunction and disruption via elevation of Ca(2+) and ROS in Candida albicans. Int J Biochem Cell Biol. 2017;85:114–122. doi:10.1016/j.biocel.2017.02.006
   PubMed Web of Science ®Google Scholar
• Spengler G, Gajdacs M, Donadu MG, et al. Evaluation of the antimicrobial and antivirulent potential of essential oils isolated from Juniperus oxycedrus L. ssp. macrocarpa aerial parts. Microorganisms. 2022;10(4):758. doi:10.3390/microorganisms10040758
   PubMed Web of Science ®Google Scholar
• Hamdy R, Fayed B, Hamoda AM, et al. Essential oil-based design and development of novel anti-Candida azoles formulation. Molecules. 2020;25(6):1463. doi:10.3390/molecules25061463
   PubMed Web of Science ®Google Scholar
• Cid-Chevecich C, Muller-Sepulveda A, Jara JA, et al. Origanum vulgare L. essential oil inhibits virulence patterns of Candida spp. and potentiates the effects of fluconazole and nystatin in vitro. BMC Complement Med Ther. 2022;22(1):39. doi:10.1186/s12906-022-03518-z
   PubMedGoogle Scholar
• Lohse MB, Gulati M, Johnson AD, et al. Development and regulation of single- and multi-species Candida albicans biofilms. Nat Rev Microbiol. 2018;16(1):19–31. doi:10.1038/nrmicro.2017.107
   PubMed Web of Science ®Google Scholar
• Desai JV, Mitchell AP, Ghannoum M, Parsek M, Whiteley M, Mukherjee P. Candida albicans biofilm development and its genetic control. Microbiol Spectr. 2015;3(3). doi:10.1128/microbiolspec.MB-0005-2014
   PubMedGoogle Scholar
• Oppenheimer-Shaanan Y, Steinberg N, Kolodkin-Gal I. Small molecules are natural triggers for the disassembly of biofilms. Trends Microbiol. 2013;21(11):594–601. doi:10.1016/j.tim.2013.08.005
   PubMed Web of Science ®Google Scholar
• Gow NA, van de Veerdonk FL, Brown AJ, et al. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol. 2011;10:112–122. doi:10.1038/nrmicro2711
   PubMed Web of Science ®Google Scholar
• Meng L, Zhao H, Zhao S, et al. Inhibition of yeast-to-hypha transition and virulence of Candida albicans by 2-alkylaminoquinoline derivatives. Antimicrob Agents Chemother. 2019;63(4). doi:10.1128/AAC.01891-18
   PubMed Web of Science ®Google Scholar
• Maesaki S, Marichal P, Vanden Bossche H, et al. Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains. J Antimicrob Chemother. 1999;44(1):27–31. doi:10.1093/jac/44.1.27
   PubMed Web of Science ®Google Scholar
• Wu XZ, Cheng AX, Sun LM, et al. Plagiochin E, an antifungal bis(bibenzyl), exerts its antifungal activity through mitochondrial dysfunction-induced reactive oxygen species accumulation in Candida albicans. Biochim Biophys Acta. 2009;1790:770–777. doi:10.1016/j.bbagen.2009.05.002
   PubMed Web of Science ®Google Scholar
• Hwang IS, Lee J, Jin HG, et al. Amentoflavone stimulates mitochondrial dysfunction and induces apoptotic cell death in Candida albicans. Mycopathologia. 2012;173:207–218. doi:10.1007/s11046-011-9503-x
   PubMed Web of Science ®Google Scholar
• Frohlich KU, Fussi H, Ruckenstuhl C. Yeast apoptosis--from genes to pathways. Semin Cancer Biol. 2007;17:112–121. doi:10.1016/j.semcancer.2006.11.006
   PubMed Web of Science ®Google Scholar
• Tian H, Qu S, Wang Y, et al. Calcium and oxidative stress mediate perillaldehyde-induced apoptosis in Candida albicans. Appl Microbiol Biotechnol. 2017;101(8):3335–3345. doi:10.1007/s00253-017-8146-3
   PubMed Web of Science ®Google Scholar
• Hwang JH, Hwang IS, Liu QH, et al. (+)-Medioresinol leads to intracellular ROS accumulation and mitochondria-mediated apoptotic cell death in Candida albicans. Biochimie. 2012;94:1784–1793. doi:10.1016/j.biochi.2012.04.010
   PubMed Web of Science ®Google Scholar
• Chen Y, Zeng H, Tian J, et al. Dill (Anethum graveolens L.) seed essential oil induces Candida albicans apoptosis in a metacaspase-dependent manner. Fungal Biol. 2014;118(4):394–401. doi:10.1016/j.funbio.2014.02.004
   PubMed Web of Science ®Google Scholar
• Peng L, Yu Q, Zhu H, et al. The V-ATPase regulates localization of the TRP Ca(2+) channel Yvc1 in response to oxidative stress in Candida albicans. Int J Med Microbiol. 2020;310:151466. doi:10.1016/j.ijmm.2020.151466
   PubMed Web of Science ®Google Scholar
• Sharma M, Manoharlal R, Puri N, et al. Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans. Biosci Rep. 2010;30(6):391–404. doi:10.1042/BSR20090151
   PubMed Web of Science ®Google Scholar
• Bi S, Lv QZ, Wang TT, et al. SDH2 is involved in proper hypha formation and virulence in Candida albicans. Future Microbiol. 2018;13:1141–1156. doi:10.2217/fmb-2018-0033
   PubMed Web of Science ®Google Scholar
• Pasrija R, Krishnamurthy S, Prasad T, et al. Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans. J Antimicrob Chemother. 2005;55(6):905–913. doi:10.1093/jac/dki112
   PubMed Web of Science ®Google Scholar